New Key Statistics Module, Z-Score and F-Score
OTCPK:BMKDF Key Ratios
Market Cap $ M | 19.18 |
Enterprise Value $ M | 20.36 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 300.43 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -0.04 |
Beneish M-Score | -3.33 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -10.20 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -18.99 |
EV-to-EBITDA | -26.17 |
PEG | -- |
Shares Outstanding M | 90.89 |
Net Margin (%) | -937.81 |
Operating Margin % | -999.39 |
Pre-tax Margin (%) | -940.24 |
Quick Ratio | 0.28 |
Current Ratio | 0.28 |
ROA % (ttm) | -177.97 |
ROE % (ttm) | -- |
ROIC % (ttm) | -139.80 |
Dividend Yield % | -- |
Altman Z-Score | -9.27 |
Piotroski F-Score | 3.00 |
Positive ROA | N |
Positive CFROA | N |
Higher ROA y-y | N |
Cash flow > Earnings | Y |
Lower Leverage y-y | N |
Higher Current Ratio y-y | Y |
Less Shares Outstanding y-y | N |
Gross Margin Increase y-y | N |
Higher Asset Turnover y-y | Y |
BMKDF Number of Guru Trades
BMKDF Volume of Guru Trades
Gurus Latest Trades with OTCPK:BMKDF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:BMKDF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Biomark Diagnostics Inc Insider Transactions
No Available Data
News about OTCPK:BMKDF
Total 0- 1